Related by context. All words. (Click for frequent words.) 63 neurocognitive function 62 ADAS Cog 62 tissue oxygenation 61 ADAS cog 61 dyssynchrony 61 HOMA IR 61 stratifying patients 60 NIH CPSI 60 poststroke 60 Crohn Disease Activity 60 PSA nadir 60 urodynamic parameters 60 HAQ DI 60 Alzheimer Disease Assessment 60 cerebral oxygen saturation 60 ALS Functional 60 neovascular 60 myocardial viability 59 CORE OM 59 SUVmax 59 clinicopathological features 59 bronchial hyperresponsiveness 59 intravascular hemolysis 59 inotropic 59 MADRS score 59 demonstrated clinically meaningful 59 PSADT 59 clinically meaningful improvements 59 hippocampal atrophy 59 platelet reactivity 59 arterial oxygen saturation 59 Y BOCS 59 WOMAC pain 59 HbA 1c levels 59 SELENA SLEDAI 59 pretest probability 59 ventricular remodeling 59 metabolic dysregulation 59 anti Xa 58 myocardial necrosis 58 CTEPH 58 posttransplant 58 symptomatic VTE 58 autonomic dysfunction 58 spirometric 58 comorbid diagnoses 58 psychosocial variables 58 CPAP adherence 58 pulmonary exacerbations 58 symptomatic intracranial 58 cerebral oxygenation 58 hematologic parameters 58 MMSE score 58 prognostic variables 58 premorbid 58 liver histology 58 hepatic fibrosis 58 overt nephropathy 58 Brief Psychiatric 58 Unified Parkinson Disease 58 carotid IMT 58 Neuropsychiatric Inventory NPI 58 colorectal adenoma 58 SGRQ 58 multivariable adjusted 58 ventilatory 58 mRS 58 WOMAC scores 58 neurocognitive deficits 58 chemosensitivity 58 Kaplan Meier curves 58 euthymic patients 58 NYHA functional class 58 nonsignificant trend 58 albumin excretion rate 58 % CI #.#-#.# [007] 58 prospectively defined 58 EQ 5D 57 hemodynamic parameters 57 echocardiographic parameters 57 clinically meaningful improvement 57 UPDRS 57 angiographic outcomes 57 lactate dehydrogenase 57 STRIDE PD 57 albumin excretion 57 multivariable analysis 57 Scale cognitive subscale 57 glycosylated hemoglobin HbA1c 57 exploratory endpoints 57 histologic subtype 57 pT3 57 EGFR mutation status 57 myocardial ischaemia 57 oncologic outcomes 57 affective psychosis 57 prognostic indicators 57 antithrombotic therapy 57 myocardial reperfusion 57 perfusion abnormalities 57 Glasgow Coma Scale 57 Visual Analogue Scale VAS 57 morbidity mortality 57 FDG uptake 57 NIHSS score 57 chronicity 57 ADCS CGIC 57 cognitive affective 57 EDSS score 57 prespecified secondary 57 clinically meaningful reductions 57 leukocyte counts 57 femoral neck fracture 57 posttreatment 57 IntroductionThe 57 Rating Scale UPDRS 57 p = .# [002] 57 intact parathyroid hormone 57 PASI scores 57 intravenous diuretics 57 NIHSS 57 statistically significant predictor 57 orthostatic 57 pharmacodynamic parameters 57 subscores 57 inflammatory biomarkers 57 electrophysiologic 57 Viral load 57 PNH patients 57 HER2 expression 57 postoperative AF 57 IOP lowering 57 comorbid depression 57 pharmacological therapies 57 Visual acuity 57 Fibromyalgia Impact Questionnaire 57 preintervention 56 LV dysfunction 56 AST ALT 56 radiographic outcomes 56 intracerebral haemorrhage 56 intraventricular 56 ER CHOP 56 NNT = 56 akinesia 56 Scale EDSS 56 genotypic resistance 56 conditional logistic regression 56 haematologic 56 proliferative diabetic retinopathy 56 % CI #.#-#.# [008] 56 coronary calcification 56 baseline LDH 56 esophageal carcinoma 56 postoperative complication 56 serum BDNF 56 diabetic microvascular complications 56 CCyR 56 DAS# CRP 56 ADCS ADL 56 progression TTP 56 parkinsonian symptoms 56 tic severity 56 unfavorable cytogenetics 56 Postoperatively 56 serum urate levels 56 comorbid psychiatric 56 neurologic progression 56 oxygen desaturation 56 thyroid carcinoma 56 depressive symptom 56 exudative AMD 56 lymph node metastasis 56 glomerular filtration 56 periprocedural 56 depressive symptomatology 56 peri procedural 56 univariate 56 SPECT CT imaging 56 intraobserver 56 Montgomery Åsberg Depression 56 underwent resection 56 alanine aminotransferase ALT 56 Secondary endpoints included 56 HSCT 56 CDAI score 56 F FDG PET 56 creatine kinase MB 56 expiratory flow 56 EDSS scores 56 elevated IOP 56 systolic function 56 tumor histology 56 bivariate 56 attain statistical significance 56 statistically significant p = 56 comorbid anxiety 56 cardiac dysfunction 56 atheroma volume 56 multivariable analyzes 56 Injury Severity Score 56 Index CDAI 56 tipranavir r 56 PSA kinetics 56 PCWP 56 hemodynamic variables 56 neurobehavioural 56 SCr 56 ejection fraction EF 56 p = NS 56 anti JCV antibodies 56 specific antigen PSA 56 cerebral perfusion 55 surrogate markers 55 oral anticoagulation 55 RNFL thickness 55 contrast echocardiography 55 multiple linear regression 55 locoregional disease 55 HDRS 55 gastroduodenal 55 cirrhotic patients 55 Visual Analog 55 subclinical atherosclerosis 55 graft dysfunction 55 Multivariate logistic regression 55 neuropsychological impairment 55 scintigraphic 55 interrater reliability 55 histological subtype 55 perioperative mortality 55 multivariate adjustment 55 left ventricular diastolic 55 obstructive CAD 55 neuromotor 55 treat NNT 55 Montgomery Asberg Depression 55 Neuropsychiatric Inventory 55 leukocyte count 55 prognostic significance 55 neurocognitive functioning 55 haemodynamic 55 artery stenosis 55 postprocedure 55 multivariate Cox 55 Global Impression CGI 55 diabetic polyneuropathy 55 atherothrombotic 55 serum biomarker 55 clinicopathological 55 Severity Index PASI 55 p = #.# [003] 55 Suicidal ideation 55 liver metastasis 55 hemodynamic measurements 55 thrombotic complications 55 lymphocyte count 55 noncardiac 55 serum urate 55 cardiac repolarization 55 univariate analyzes 55 radiographic findings 55 postural sway 55 interobserver 55 PROactive study 55 death reinfarction 55 metabolic parameters 55 subthreshold 55 #OHD 55 demyelinating 55 plasma cortisol 55 neurosensory 55 graft patency 55 extrapyramidal symptoms 55 fructosamine 55 extracapsular extension 55 adjuvant therapies 55 pulmonary dysfunction 55 bronchoalveolar lavage 55 perioperative morbidity 55 CIMZIA TM certolizumab pegol 55 cardiac autonomic 55 EGFR mutation positive 55 nasal symptom 55 pharmacodynamic endpoints 55 serologically active patients 55 pharmacodynamic PD 55 subscales 55 serum magnesium 55 haematological 55 doxorubicin docetaxel 55 univariate analysis 55 postdischarge 55 virological response 55 preoperative PSA 55 ispinesib administered 55 BEXXAR Therapeutic Regimen 55 6MWD 55 Score DAS 55 nephrogenic 55 nerve conduction velocity 55 hypoperfusion 55 parasitaemia 55 interobserver reliability 55 adenoma recurrence 55 intravascular volume 55 biopsy Gleason 55 Symptom severity 55 psychosocial functioning 55 oncological outcomes 55 postintervention 55 LV ejection fraction 55 CI -#.# 55 mechanical dyssynchrony 55 handgrip strength 55 sacral neuromodulation 55 obstructive coronary artery 55 multivariate analyzes 55 prospectively stratified 55 non squamous histology 55 nonpharmacologic 55 blood oxygenation 55 CD# upregulation 55 recurrent glioblastoma multiforme 55 neurocognitive outcomes 55 neovascularisation 55 node metastases 55 aspartate aminotransferase AST 55 concomitant medications 55 venous thromboembolic disease 55 HRQoL 55 Psoriasis Area 54 intraclass correlation coefficient 54 Multivariate analysis revealed 54 enthesitis 54 T2DM 54 VADT 54 subclinical disease 54 perineural invasion 54 gait disturbances 54 ischemic lesions 54 postoperative mortality 54 Carotid endarterectomy 54 psychiatric comorbidity 54 pulmonary capillary wedge 54 completely resected 54 hyperacute 54 urine albumin 54 multivariable logistic regression 54 glycated hemoglobin levels 54 corneal thickness 54 nonsignificant 54 plasma pharmacokinetics 54 HER2 overexpression 54 Kaplan Meier curve 54 MMSE scores 54 nasal polyposis 54 infarct size 54 ejection fractions 54 multivariate logistic regression 54 postoperative radiotherapy 54 DLQI 54 Index CDAI score 54 recurrent venous thromboembolism 54 serum lipid levels 54 monoclonal gammopathy 54 chi squared 54 meta analytic 54 carotid stenosis 54 hypercoagulable 54 neutrophil counts 54 meta regression 54 corticosteroid dose 54 HbA1C levels 54 pulmonary toxicity 54 visceral adiposity 54 laterality 54 experienced virologic failure 54 retinal thickness 54 symptom severity 54 hyperalgesia 54 primary aldosteronism 54 Lumbar spine 54 Platelet counts 54 pCR 54 SSc 54 OSDI 54 Genetic predisposition 54 BMI z 54 morphometric vertebral fractures 54 diabetic kidney 54 lactate dehydrogenase LDH 54 convergent validity 54 elevated bilirubin 54 corneal staining 54 Skin sterol 54 Secondary endpoints include 54 biochemical recurrence 54 serum ALT 54 CSF biomarkers 54 % CI #.#-#.# [001] 54 allogeneic HSCT 54 Poisson regression 54 bioprosthetic valve 54 HRQOL 54 reinfarction 54 = #.#-#.# 54 β blockers 54 angiographically 54 RBC transfusion 54 tumor necrosis 54 Free Survival PFS 54 Endothelial function 54 QTcF 54 Cognitive behavioral 54 d dimer 54 interindividual variability 54 IPAH 54 peak VO2 54 serum parathyroid hormone 54 diabetes mellitus DM 54 Comorbidity 54 linear regression analyzes 54 complete cytogenetic response 54 postoperative morbidity 54 gastric cardia 54 renal scarring 54 lesional 54 prognostically 54 pathophysiological mechanisms 54 HRQL 54 GH deficiency 54 LVNC 54 OnDose TM 54 Retreatment 54 prospective multicenter study 54 CHADS2 54 kidney allograft 54 Ocular Surface Disease 54 gastric carcinoma 54 inotropes 54 % Confidence Interval 54 antiplatelet therapies 54 inspiratory flow 54 CFQ R 54 androgen suppression 54 comorbidity 54 Main Outcome Measures 54 PD2i ® 54 genotype phenotype 54 Hb A1C 54 hepatic encephalopathy HE 54 hemoglobin Hb 54 psychiatric comorbidities 54 cranial irradiation 54 Prognostic factors 54 inhaled iloprost 54 neurologic sequelae 54 binary logistic regression 54 moderately emetogenic 54 coagulopathy 54 cardiac perfusion 54 perioperative complications 54 Timed Walk 54 R0 resection 54 interobserver agreement 54 response pCR 54 pharmacokinetic parameters 54 EGFR expression 54 Forced Vital 54 CDAI 54 logistic regression analysis 54 LVEF 54 bi ventricular pacing 54 predictive biomarker 54 stepwise regression 54 serum PTH 54 Health Assessment Questionnaire 54 paricalcitol 54 hematologic toxicity 54 CP CPPS 54 recurrent ischemia 54 affective psychoses 54 UPDRS scores 54 postop 54 tamponade 54 symptomatic intracranial hemorrhage 53 relapsed MM 53 neurobehavioral functioning 53 childhood acute lymphoblastic 53 exhaled NO 53 constipation predominant IBS 53 radiotherapy RT 53 motor neuron degeneration 53 myocardial perfusion 53 eNO 53 posttest 53 serum biomarkers 53 System IPSS 53 Scale PANSS 53 neurodevelopmental impairment 53 subsyndromal 53 hemoglobin A1c levels 53 UPDRS motor 53 urinary N telopeptide 53 smoldering myeloma 53 parasitological 53 APOE genotype 53 systolic dysfunction 53 ventricular dysfunction 53 intima media thickness 53 cortical atrophy 53 Kruskal Wallis test 53 PD2i R 53 urate levels 53 choroidal vasculopathy 53 FDG-PET/CT 53 pharmacological interventions 53 postinjury 53 Expanded Disability Status 53 subthreshold depression 53 locoregional 53 macroalbuminuria 53 sweat chloride 53 Logistic regression 53 Ejection Fraction 53 Primary endpoints 53 D dimer 53 chronic periodontitis 53 antioxidant supplementation 53 Secondary efficacy endpoints 53 aortic atherosclerosis 53 curability 53 paraprotein 53 atrial tachyarrhythmias 53 PANSS 53 daytime somnolence 53 QoL 53 renal cysts 53 HF hospitalization 53 lower extremity amputation 53 definite stent thrombosis 53 IV NSCLC 53 sustained virological response 53 Logistic regression analysis 53 serum aminotransferase levels 53 repolarization 53 PANSS total 53 Renal Cell Carcinoma RCC 53 Rating Scale MADRS 53 Preoperatively 53 postural stability 53 viral kinetics 53 postoperative atrial fibrillation 53 neutropaenia 53 acromegalic patients 53 etiologic 53 CD# expression [002] 53 KRAS status 53 bronchopulmonary dysplasia BPD 53 schizophrenia CIAS 53 eculizumab therapy 53 Rating Scale BPRS 53 fractional anisotropy 53 Zevalin consolidation 53 affective disorders 53 hepatic enzymes 53 carotid artery stenting CAS 53 EORTC QLQ C# 53 Serum creatinine 53 composite endpoint 53 serum vitamin D 53 EpCAM expression 53 POAG 53 pathophysiological processes 53 IL 1ß 53 radiochemotherapy 53 Thrombolysis 53 confirmed CCyR 53 proliferative retinopathy 53 Tasigna prolongs 53 cortical stimulation 53 P = .# 53 hippocampal volumes 53 macrovascular events 53 postoperative pulmonary 53 pulmonary exacerbation 53 subscale scores 53 ABL1 53 periprosthetic infection 53 prostate carcinoma 53 Subarachnoid hemorrhage 53 multivariate regression 53 HBeAg 53 Negative Syndrome 53 anthropometric measures 53 rheumatologic 53 estimated GFR 53 hematopoietic cancers 53 plasma renin 53 binary restenosis 53 NMIBC 53 PRESEPT study 53 aminotransferases 53 atherogenic dyslipidemia 53 hip BMD 53 Genomic Grade 53 DAS# [002] 53 foveal thickness 53 HIV HCV coinfected 53 NIS LL 53 cognitive domains 53 fibrosis progression 53 mg/m2 dose 53 PANSS scores 53 patients undergoing CABG 53 erythrocyte sedimentation rate 53 oxygen saturation SpO2 53 indolent lymphomas 53 CIBIC + 53 intravesical therapy 53 selective cerebral perfusion 53 Oncotype 53 OSAHS 53 nonadherence 53 distant metastasis 53 Cystatin C 53 Univariate analysis 53 myocardial function 53 malignant neoplasm 53 graft occlusion 53 colonoscopic 53 FDG PET imaging 53 mean ± SEM 53 endometrial thickness 53 salmeterol fluticasone propionate 53 EDSS 53 Ejection fraction 53 airway hyperresponsiveness 53 epoetin alpha 53 growth hormone secretion 53 nonalcoholic steatohepatitis NASH 53 Ishak fibrosis score 53 Score DAS# 53 parkinsonian 53 silent ischemia 53 mammographic density 53 lymphovascular invasion 53 nomograms 53 Parkinsonian symptoms 53 logistic regression analyzes 53 serum sodium levels 53 International Prognostic Scoring 53 arterial thickening 53 hemodialysis patients 53 carotid bruit 53 covariate 53 MMSE 53 somatoform disorders 53 dosimetric 53 EuroSCORE 53 NPM1 mutation 53 plasma proteome 53 thromboembolic 53 hepatic insulin sensitivity 53 Interrater reliability 53 glycosylated hemoglobin levels 53 virological suppression 53 HRCT 53 HAMD 53 prodromal symptoms 53 clinically localized prostate 53 glaucomatous 53 Main Outcome Measure 53 Cronbach alpha 53 ankle dorsiflexion 52 thyrotropin levels 52 choroidal neovascularization 52 histological subtypes 52 APACHE II 52 Kaplan Meier survival 52 confidence intervals CIs 52 mucosal healing 52 serum albumin 52 myocardial dysfunction 52 prostate cancer CaP 52 Cystic Fibrosis Questionnaire Revised 52 Echocardiographic 52 hematological parameters 52 left ventricular systolic 52 antiphospholipid syndrome 52 underwent coronary angiography 52 ‰ ¥ 52 serum lipid 52 myocardial infarct size 52 prostate cancer PCa 52 carotid artery narrowing 52 ICD therapy 52 intra abdominal abscess 52 intraclass correlation coefficients 52 p# biomarker 52 T1a 52 cerebral ischemia 52 Seattle Angina Questionnaire 52 elevated LDH 52 tumoral 52 CVD mortality 52 intestinal permeability 52 serum homocysteine 52 Erythropoietic therapies may 52 FluCAM arm 52 Severity MSCS score 52 leukocytosis 52 urolithiasis 52 Ischemic 52 sociodemographic factors 52 predictive validity 52 nonalcoholic steatohepatitis 52 axial length 52 methotrexate monotherapy 52 hemoglobin concentration 52 lung metastasis 52 HORIZONS AMI trial 52 p ≤ 52 medication nonadherence 52 Capacity FVC 52 ischemia induced 52 pericardial effusion 52 haematological toxicity 52 pT2 52 Charlson Comorbidity Index 52 amnestic MCI 52 surrogate endpoint 52 Thal Dex 52 comorbid disorders 52 tracer uptake 52 hemodynamic instability 52 acute ischemia 52 troponin T 52 Leydig cell 52 radiographic progression 52 renal biopsy 52 microalbuminuria 52 Circulating tumor cells 52 immunotoxicity 52 CLBP 52 interferon ribavirin 52 myocardial fibrosis 52 intracoronary 52 hemorrhagic complications 52 Histologic 52 Subgroup analyzes 52 bladder carcinoma 52 aldosterone antagonist 52 arteriography 52 cytopenias 52 neuropsychological impairments 52 secondary efficacy endpoint 52 ETDRS 52 viral titers 52 knee osteoarthritis OA 52 LAGB 52 Multiple linear regression 52 exhaled nitric oxide 52 % CI #.#-#.# [003] 52 P ≤ 52 residual stenosis 52 prespecified 52 Kaplan Meier analysis 52 euthymic 52 DVT PE 52 SERCA2a 52 adenoma detection 52 ROC curves 52 relapsed AML 52 CIN3 52 endophenotypes 52 postoperative chemotherapy 52 antitumor efficacy 52 oral prednisolone 52 neurocognitive impairment 52 serum HBV DNA 52 plain radiographs 52 cerebrovascular events 52 Dyspnea 52 tapentadol ER 52 HBeAg seroconversion 52 lumbar disk herniation 52 explanatory variables 52 carotid artery intima media 52 plasma triglycerides 52 serum PSA 52 lymphocytic 52 organ perfusion 52 multivariable adjustment 52 hemoglobin concentrations 52 #F FDG PET 52 CFTR function 52 percutaneous biopsy 52 sputum eosinophils 52 maximal treadmill 52 dyslipidaemia 52 imatinib therapy 52 sociodemographic characteristics 52 logistic regression model 52 HBeAg negative patients 52 postoperative infections 52 cTnI 52 NLX P# 52 Liver biopsy 52 Mathematical modeling 52 cerebellar vermis 52 glucocorticoid hormones 52 thrombolytic agents 52 hyper IgE syndrome 52 psychopathological symptoms 52 pretransplant 52 prospective longitudinal 52 neuropathological 52 stent binary restenosis 52 nonoperative treatment 52 plus octreotide LAR 52 coronary stenosis 52 Depressive symptoms 52 aminotransferase ALT 52 anti JCV antibody 52 alexithymia 52 linear regression analysis 52 pain subscale 52 plasma leptin 52 AGILECT R 52 upper gastrointestinal bleeding 52 ipsilateral stroke 52 EBUS FNA 52 logistic regression models 52 HbA 1c 52 PsA 52 IBDQ 52 diagnostic modality 52 induced sputum 52 esophageal manometry 52 neurologic impairment 52 mediastinal 52 generalized estimating 52 timepoint 52 atherosclerosis regression 52 ECLS 52 nonfasting triglyceride levels 52 left ventricular LV 52 metastatic lymph nodes 52 schizophreniform disorder 52 NATRECOR R 52 functional mitral regurgitation 52 hippocampal volume 52 postoperative hemorrhage 52 Glomerular filtration rate 52 SIMPADICO 52 dopaminergic therapy 52 multivariate regression analysis 52 acetabular dysplasia 52 FACIT Fatigue 52 coagulation abnormalities 52 achieved statistical significance 52 differentiated thyroid 52 baseline HbA1c 52 granulocyte 52 coinfected patients 52 sensitivity specificity 52 prognostic indicator 52 nodal metastasis 52 unresectable HCC 52 HNSCC 52 vasopressor 52 submaximal 52 virologic response 52 CYP#D# inhibitor 52 airway responsiveness 52 endocrine therapies 52 aromatase inhibitor therapy 52 nonmetastatic 52 Fractional Flow Reserve 52 thickness IMT 52 hyperglycaemia 52 CR nPR 52 pyridostigmine 52 empirically validated 52 anemia hemoglobin 52 cecal intubation 52 highest tertile 52 atherothrombotic disease 52 protease inhibitor mutations 52 induce remission 52 coronary revascularization 52 adrenalectomy 52 experimentally induced 52 T2 lesion volume 52 PITX2 52 adverse cytogenetics 52 covariance ANCOVA 52 PKC inhibitors 52 alanine aminotransferase 52 cytoreductive nephrectomy 52 hemodilution 52 primary patency 52 plasma creatinine 52 neurologic dysfunction 52 cardioembolic stroke 52 Oswestry Disability Index 52 subjective sleepiness 52 aortic insufficiency 52 troponins 52 histologic 52 baroreceptor 52 multivessel coronary artery 52 colorectal cancer liver metastases 52 hepatocellular carcinomas 52 UPDRS Part III 51 arterial calcification 51 mL/min/#.# m 2 51 p = #.# [002] 51 serum phosphate levels 51 autologous transplantation 51 androgen ablation 51 NSTEMI 51 NNRTI resistance 51 urinary excretion 51 glycated hemoglobin HbA1c 51 antibody titer 51 nonobstructive 51 immune reconstitution 51 arterial thromboembolism 51 coronary revascularization procedures 51 Coronary artery bypass grafting 51 nonfatal MI 51 independent prognostic marker 51 pressure natriuresis 51 chronic LBP 51 surgical decompression 51 intracranial hemorrhage ICH 51 Endothelial dysfunction 51 CMV reactivation 51 extramedullary 51 rebleeding 51 antidepressant efficacy 51 neonatal morbidity 51 achieved ACR# 51 RECIST Response Evaluation Criteria 51 cytologic 51 pharmacologic treatments 51 microbiologic 51 serum bilirubin 51 periprocedural MI 51 serum potassium 51 preoperative chemotherapy 51 anterior temporal 51 SGPT 51 elevated ALT 51 flow mediated dilation 51 decompensated cirrhosis 51 clinicopathologic 51 sub maximal 51 estimated glomerular filtration 51 nonparametric 51 coronary stenoses 51 fatigability 51 syndromal 51 Kaplan Meier estimates 51 oral anticoagulant therapy 51 forced expiratory 51 serum cotinine levels 51 Subgroup analysis 51 Fasting plasma glucose 51 histologies 51 ACUITY trial 51 visceral metastases 51 Breslow thickness 51 fragility fracture 51 rearfoot 51 aspartate aminotransferase 51 HER2 amplification 51 microbiologically evaluable 51 BrachySil TM 51 DAS# scores 51 bronchoalveolar lavage fluid 51 glutamate glutamine 51 nondiabetic patients 51 persistency mortality 51 Cardiotoxicity 51 phosphorylated tau 51 lymphocytosis 51 cTnT levels 51 salivary cortisol 51 cerebral oximetry 51 urinary albumin 51 Target Lesion Revascularization TLR 51 sJIA 51 docetaxel pretreated 51 amisulpride 51 cardiac magnetic resonance